Table 2. Differential expression of genes in the JAK–STAT signaling pathway in MPN patients.
Gene | Group 1 | Group 2 | Group 3 | |
1 | ACTB | 10.9 | 7.1 | (−3.1) |
2 | SOCS3 | 7.5 | 2.2 | (−1.7) |
3 | JAK2 | 4.4 | (2.7) | (2.0) |
4 | JAK3 | 4.2 | (2.0) | (1.7) |
5 | FAS | 4.1 | (2.4) | 2.7 |
6 | SPI1 | 3.9 | 2.1 | (1.6) |
7 | STAT5B | 3.6 | (1.5) | (−1.5) |
8 | IFNGR1 | 2.7 | (1.6) | (1.1) |
9 | SP1 | 2.6 | (1.9) | (1.3) |
10 | IRF9 | 2.6 | (1.6) | (−1.1) |
11 | STUB1 | 2.4 | (1.6) | (1.8) |
12 | GAPDH | 2.3 | (−1.2) | 2.0 |
13 | JUNB | 2.2 | (−1.1) | (−1.3) |
14 | FCGR1A | 2.1 | (1.3) | −2.2 |
15 | STAT3 | 1.7 | (1.5) | (1.1) |
16 | SRC | −1.6 | (1.1) | (1.3) |
17 | HMGA1 | −1.6 | (−1.2) | (−1.4) |
18 | HPRT1 | −1.8 | (−1.6) | −1.5 |
19 | IL2RA | −1.9 | (−1.6) | −1.8 |
20 | CSF2RB | −1.9 | −1.6 | −3.5 |
21 | SOCS1 | −2.2 | −2.0 | −3.9 |
22 | IL20 | −2.2 | (1.0) | (−2.0) |
23 | TYK2 | −2.3 | (−1.4) | −2.0 |
24 | SOCS2 | −2.3 | (−1.4) | (−2.5) |
25 | EPOR | −2.3 | (−1.5) | −2.2 |
26 | YY1 | −2.5 | −1.7 | −2.8 |
27 | STAT1 | −2.5 | (−1.5) | −2.6 |
28 | SOCS4 | −2.5 | (−1.6) | (−2.5) |
29 | MMP3 | −2.5 | (−1.4) | (−2.8) |
30 | IL2RG | −2.6 | −2.1 | −3.4 |
31 | IL4 | −2.7 | (−1.6) | (−2.8) |
32 | SOCS5 | −2.7 | (−1.6) | (−2.8) |
33 | PTPRC | −2.9 | (−1.8) | −3.5 |
34 | JAK1 | −2.9 | (−1.6) | −2.5 |
35 | USF1 | −3.3 | −1.7 | −2.8 |
36 | OAS1 | −3.3 | (−1.5) | (−2.3) |
37 | SLA2 | −3.4 | (−1.3) | (−1.6) |
38 | IL6ST | −3.5 | (−1.6) | −4.7 |
39 | MYC | −3.6 | (−2.1) | −2.1 |
40 | IFNG | −4.1 | −2.3 | −2.0 |
41 | NR3C1 | −4.2 | −2.4 | −4.3 |
42 | SMAD2 | −4.2 | (−1.7) | −2.5 |
43 | PPP2R1A | −4.3 | −2.5 | −3.3 |
44 | IRF1 | −4.5 | −2.1 | −4.5 |
45 | GATA3 | −5.6 | −2.5 | −2.4 |
46 | STAT2 | −5.8 | −2.2 | −3.8 |
47 | IL10RA | −6.4 | −2.6 | −4.5 |
48 | CSF1R | −8.2 | −2.9 | −3.6 |
49 | SH2B1 | −8.7 | −3.4 | −5.2 |
50 | RPL13A | −9.1 | −3.3 | −4.0 |
51 | SIT1 | −9.6 | −3.0 | −4.7 |
52 | STAT4 | −11.0 | −3.6 | −5.3 |
53 | A2M | −11.3 | −3.7 | −3.8 |
Selected genes analyzed by JAK–STAT-related PCR array that showed statistically significant (p<0.05) up- or downregulation between the group 1 and the control group are shown. The magnitude of differences for groups 2 and 3 are also shown. Positive and negative numbers indicate up- and downregulation, respectively. Numbers in parentheses indicate a lack of statistical significance (p>0.05) in comparison with the control group.